Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Feb;74(2):515–519. doi: 10.1073/pnas.74.2.515

Catecholamine binding to the beta-adrenergic receptor.

R J Lefkowitz, L T Williams
PMCID: PMC392320  PMID: 15249

Abstract

The adenylate cyclase-coupled beta-adrenergic receptors of frog erythrocyte membranes have been identified by direct radioligand binding techniques using the potent catecholamine agonist (+/-)[3H]hydroxybenzylisproterenol (2-[3, 4-dihydroxyphenyl]-2-hydroxy-1', 1'-dimethyl-2'-[4-hydroxyphenyl]-diethylamine). The successful experimental conditions included the use of (i) high concentrations of catechol and ascorbic acid to suppress nonreceptor binding, (ii) a very potent radiolabeled catecholamine (10 times more potent than isoproterenol), and (iii) membranes rich in binding sites for beta-adrenergic receptors. Thus, previous problems in accomplishing successful catecholamine binding to the beta-receptors have been overcome. The binding sites identified with (+/-)[3H]hydroxybenzylisoproterenol in the erythrocyte membranes have all the characteristics expected of true beta-adrenergic receptors. These include rapidity of binding, saturability, specificity for beta-agonists and antagonists, and stereospecificity [(-)isomers more potent than (+)isomers]. Physiologically inactive compounds containing a catechol moiety do not compete for occupancy of these binding sites. Dissociation of the radiolabeled agonist from the receptors is slow and incomplete in the absence of guanine nucleotides. In the presence of nucleotide, however, dissociation is rapid and complete. beta-Adrenergic agonists and antagonists compete for the (+/-)[3H]hydroxybenzylisoproterenol binding sites in a fashion parallel to their competition for the receptors, as previously delineated with the beta-adrenergic antagonist (-)[3H]dihydroalprenolol.

Full text

PDF
515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atlas D., Steer M. L., Levitzki A. Stereospecific binding of propranolol and catecholamines to the beta-adrenergic receptor. Proc Natl Acad Sci U S A. 1974 Oct;71(10):4246–4248. doi: 10.1073/pnas.71.10.4246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aurbach G. D., Fedak S. A., Woodard C. J., Palmer J. S., Hauser D., Troxler F. Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site. Science. 1974 Dec 27;186(4170):1223–1224. doi: 10.1126/science.186.4170.1223. [DOI] [PubMed] [Google Scholar]
  3. Bilezikian J. P., Aurbach G. D. A beta-adrenergic receptor of the turkey erythrocyte. II. Characterization and solubilization of the receptor. J Biol Chem. 1973 Aug 25;248(16):5584–5589. [PubMed] [Google Scholar]
  4. Brown E. M., Aurbach G. D. Beta-Adrenergic receptor interactions. Characterization of iodohydroxybenzylpindolol as a specific ligand. J Biol Chem. 1976 Mar 10;251(5):1232–1238. [PubMed] [Google Scholar]
  5. Brunton L. L., Wiklund R. A., Van Arsdale P. M., Gilman A. G. Binding of (3H)prostaglandin E1 to putative receptors linked to adenylate cyclase of cultured cell clones. J Biol Chem. 1976 May 25;251(10):3037–3044. [PubMed] [Google Scholar]
  6. Burt D. R., Enna S. J., Creese I., Snyder S. H. Dopamine receptor binding in the corpus striatum of mammalian brain. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4655–4659. doi: 10.1073/pnas.72.11.4655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bylund D. B., Snyder S. H. Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol. 1976 Jul;12(4):568–580. [PubMed] [Google Scholar]
  8. Caron M. G., Lefkowitz R. J. Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes. J Biol Chem. 1976 Apr 25;251(8):2374–2384. [PubMed] [Google Scholar]
  9. Cuatrecasas P., Tell G. P., Sica V., Parikh I., Chang K. J. Noradrenaline binding and the search for catecholamine receptors. Nature. 1974 Jan 11;247(5436):92–97. doi: 10.1038/247092a0. [DOI] [PubMed] [Google Scholar]
  10. Harden T. K., Wolfe B. B., Molinoff P. B. Binding of iodinated beta adrenergic antagonists to proteins derived from rat heart. Mol Pharmacol. 1976 Jan;12(1):1–15. [PubMed] [Google Scholar]
  11. Kebabian J. W., Zatz M., Romero J. A., Axelrod J. Rapid changes in rat pineal beta-adrenergic receptor: alterations in l-(3H)alprenolol binding and adenylate cyclase. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3735–3739. doi: 10.1073/pnas.72.9.3735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Lefkowitz R. J., Haber E. A fraction of the ventricular myocardium that has the specificity of the cardiac beta-adrenergic receptor. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1773–1777. doi: 10.1073/pnas.68.8.1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lefkowitz R. J. Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists. Biochem Pharmacol. 1975 Sep 15;24(18):1651–1658. doi: 10.1016/0006-2952(75)90001-5. [DOI] [PubMed] [Google Scholar]
  15. Lefkowitz R. J., Limbird L. E., Mukherjee C., Caron M. G. The beta-adrenergic receptor and adenylate cyclase. Biochim Biophys Acta. 1976 Apr 13;457(1):1–39. doi: 10.1016/0304-4157(76)90012-5. [DOI] [PubMed] [Google Scholar]
  16. Lefkowitz R. J., Mukherjee C., Coverstone M., Caron M. G. Stereospecific (3H)(minus)-alprenolol binding sites, beta-adrenergic receptors and adenylate cyclase. Biochem Biophys Res Commun. 1974 Sep 23;60(2):703–709. doi: 10.1016/0006-291x(74)90297-6. [DOI] [PubMed] [Google Scholar]
  17. Lefkowitz R. J., Mullikin D., Caron M. G. Regulation of beta-adrenergic receptors by guanyl-5'-yl imidodiphosphate and other purine nucleotides. J Biol Chem. 1976 Aug 10;251(15):4686–4692. [PubMed] [Google Scholar]
  18. Lefkowitz R. J., Sharp G. W., Haber E. Specific binding of -adrenergic catecholamines to a subcellular fraction from cardiac muscle. J Biol Chem. 1973 Jan 10;248(1):342–349. [PubMed] [Google Scholar]
  19. Lefkowitz R. J. The beta-adrenergic receptor. Life Sci. 1976 Mar 1;18(5):461–472. doi: 10.1016/0024-3205(76)90323-4. [DOI] [PubMed] [Google Scholar]
  20. Levitzki A., Atlas D., Steer M. L. The binding characteristics and number of beta-adrenergic receptors on the turkey erythrocyte. Proc Natl Acad Sci U S A. 1974 Jul;71(7):2773–2776. doi: 10.1073/pnas.71.7.2773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Maguire M. E., Van Arsdale P. M., Gilman A. G. An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor. Mol Pharmacol. 1976 Mar;12(2):335–339. [PubMed] [Google Scholar]
  22. Maguire M. E., Wiklund R. A., Anderson H. J., Gilman A. G. Binding of (125I)iodohydroxybenzylpindolol to putative beta-adrenergic receptors of rat glioma cells and other cell clones. J Biol Chem. 1976 Mar 10;251(5):1221–1231. [PubMed] [Google Scholar]
  23. Mickey J. V., Tate R., Mullikin D., Lefkowitz R. J. Regulation of adenylate cyclase-coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro. Mol Pharmacol. 1976 May;12(3):409–419. [PubMed] [Google Scholar]
  24. Mickey J., Tate R., Lefkowitz R. J. Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro. J Biol Chem. 1975 Jul 25;250(14):5727–5729. [PubMed] [Google Scholar]
  25. Mukherjee C., Caron M. G., Coverstone M., Lefkowitz R. J. Identification of adenylate cyclase-coupled beta-adrenergic receptors in frog erythrocytes with (minus)-[3-H] alprenolol. J Biol Chem. 1975 Jul 10;250(13):4869–4876. [PubMed] [Google Scholar]
  26. Mukherjee C., Caron M. G., Lefkowitz R. J. Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites. Proc Natl Acad Sci U S A. 1975 May;72(5):1945–1949. doi: 10.1073/pnas.72.5.1945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mukherjee C., Caron M. G., Lefkowitz R. J. Regulation of adenylate cyclase coupled beta-adrenergic receptors by beta-adrenergic catecholamines. Endocrinology. 1976 Aug;99(2):347–357. doi: 10.1210/endo-99-2-347. [DOI] [PubMed] [Google Scholar]
  28. Mukherjee C., Caron M. G., Mullikin D., Lefkowitz R. J. Structure-activity relationships of adenylate cyclase-coupled beta adrenergic receptors: determination by direct binding studies. Mol Pharmacol. 1976 Jan;12(1):16–31. [PubMed] [Google Scholar]
  29. Mukherjee C., Lefkowitz R. J. Desensitization of beta-adrenergic receptors by beta-adrenergic agonists in a cell-free system: resensitization by guanosine 5'-(beta, gamma-imino)triphosphate and other purine nucleotides. Proc Natl Acad Sci U S A. 1976 May;73(5):1494–1498. doi: 10.1073/pnas.73.5.1494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pairault J., Laudat M. H. Selective identification of "true" beta-adrenergic receptors in the plasma membranes of rat adipocytes. FEBS Lett. 1975 Jan 15;50(1):61–65. doi: 10.1016/0014-5793(75)81041-6. [DOI] [PubMed] [Google Scholar]
  31. Rodbell M., Krans H. M., Pohl S. L., Birnbaumer L. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon. J Biol Chem. 1971 Mar 25;246(6):1872–1876. [PubMed] [Google Scholar]
  32. Romero J. A., Zatz M., Kebabian J. W., Axelrod J. Circadian cycles in binding of 3H-alprenolol to beta-adrenergic receptor sites in rat pineal. Nature. 1975 Dec 4;258(5534):435–436. doi: 10.1038/258435a0. [DOI] [PubMed] [Google Scholar]
  33. Schramm M., Feinstein H., Naim E., Lang E., Lasser M. Epinephrine binding to the catecholamine receptor and activation of the adenylate cyclase in erythrocyte membranes (hormone receptor- -adrenergic receptor-cyclic AMP-turkey). Proc Natl Acad Sci U S A. 1972 Feb;69(2):523–527. doi: 10.1073/pnas.69.2.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tomasi V., Koretz S., Ray T. K., Dunnick J., Marinetti G. V. Hormone action at the membrane level. II. The binding of epinephrine and glucagon to the rat liver plasma membrane. Biochim Biophys Acta. 1970 Jul 7;211(1):31–42. doi: 10.1016/0005-2736(70)90120-3. [DOI] [PubMed] [Google Scholar]
  35. Zatz M., Kebabian J. W., Romero J. A., Lefkowitz R. J., Axelrod J. Pineal beta adrenergic receptor: correlation of binding of 3H-l-alprenolol with stimulation of adenylate cyclase. J Pharmacol Exp Ther. 1976 Mar;196(3):714–722. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES